Patent · US Active

Kappa opioid receptor ligands

US7872023B2 · kind B2 · utility

1Cited by

23References

13Claims

0Family size

Assignee

Research Triangle Institute · US

Inventors

Frank Ivy Carroll · Durham, US
Hernan A. Navarro · Chapel Hill, US
Lawrence Edward Brieaddy · Raleigh, US
Scott P. Runyon · Morrisville, US
James B. Thomas · Efland, US

Key dates

Filing date	Feb 17, 2005
Grant date	Jan 18, 2011
Priority date	—
Expiry date	Jul 9, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.